Metamason Overview

  • Founded
  • 2013
Founded
  • Status
  • Out of Business
  • Latest Deal Type
  • Liquidation

Metamason General Information

Description

Developer of a personalized respiratory device designed to treat sleep apnea. The company's personalized respiratory device is a light, subtle and secure CPAP mask, designed through an application that scans face and offers a 3D printed customized and fitted printed mask, enabling sufferers to treat apnea though continuous positive airway pressure process, that works by providing a constant gentle airflow, ensuring that the passage of air in the nose is never constricted.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Primary Industry
Therapeutic Devices
Other Industries
Application Software
Primary Office
  • 811 West 7th Street
  • Suite 1146
  • Los Angeles, CA 90017
  • United States
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Metamason Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Bankruptcy: Liquidation 22-Jun-2018 00.000 Completed Bankruptcy: Liquidation
5. Early Stage VC 26-Sep-2017 000.00 00.000 Completed Startup
4. Seed Round 03-Jun-2016 000 00.000 000.00 Completed Startup
3. Accelerator/Incubator 17-May-2016 00000 Completed Startup
2. Seed Round 01-Jan-2014 $817K $817K 00.000 Completed Startup
1. Accelerator/Incubator Completed Startup
To view Metamason’s complete valuation and funding history, request access »

Metamason Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Seed 3 0,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.000
Seed 2 000,000 00.000000 00.00 00.00 00.00 00 00.00 0.000
Seed 1 12,423,463 $0.000100 $0.24 $0.24 $0.24 1x $0.24 24.75%
To view Metamason’s complete cap table history, request access »

Metamason Executive Team (9)

Name Title Board Seat Contact Info
Robin Randolph Chief Executive Officer
Robyn Woidtke Acting Vice President of Clinical Innovation & Consultant
Ryan Oenning Co-Founder & Chief Product Officer
Charles Bohlen Co-Founder & Director of Operations
Clifford Sarkin JD Co-Founder & Executive, Corporate Development
You’re viewing 5 of 9 executive team members. Get the full list »